MONROVIA, Calif.--(BUSINESS WIRE)--
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer
and marketer of implantable lenses and companion delivery systems for
the eye, and Kobe
Kanagawa Eye Clinic with locations in Tokyo and Osaka, today
announced they have entered into a multi-year Strategic Cooperation
Agreement to provide STAAR's EVO Visian ICL™ lenses as a primary and
premium option for patients seeking visual freedom from spectacles and
contact lenses through refractive eye treatment.
"We are very excited that our clinic has become a strategic partner with
STAAR Surgical Company and expect to introduce the ICL to many more
patients," said Dr. Junki Sawai, Chairman of Kobe Kanagawa Eye Clinic.
"Our clinic has performed almost 500,000 refractive surgery procedures
and has implanted the most ICL lenses in Japan for the past eight years
in a row. As a result of this agreement we intend to broaden our
promotion of the ICL as a solution that provides excellent visual
results to our patients," concluded Dr. Sawai.
Caren Mason, President & CEO of STAAR, stated, "Kobe Kanagawa Eye Clinic
is one of the largest refractive eye surgery providers in Japan, an
increasingly important market for our ICL lenses, and we are thrilled to
announce this strategic cooperation agreement. Dr. Yoshihiro Kitazawa,
Chief Medical Director of the clinic, was a recipient of our ICL
Ambassador Award in 2017 and holds STAAR’s ‘Expert Instructor’ training
and education designation. The clinic has treated many celebrity
patients. We look forward to working even more closely with the Kobe
Kanagawa team to achieve excellent vision for patients with the EVO
Visian ICL family of lenses."
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 30
years, designs, develops, manufactures and markets implantable lenses
for the eye with companion delivery systems. These lenses are intended
to provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are foldable,
which permits the surgeon to insert them through a small incision.
STAAR’s lens used in refractive surgery is called an Implantable
Collamer® Lens or “ICL”, which includes the EVO Visian ICL™ product
line. More than 800,000 Visian ICLs have been implanted to date. To
learn more about the ICL go to: www.discovericl.com.
STAAR has approximately 350 full-time equivalent employees and markets
lenses in over 75 countries. Headquartered in Monrovia, CA, the company
operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA.
For more information, please visit the Company’s website at www.staar.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180626005115/en/
Investors & Media
EVC Group
Brian Moore,
310-579-6199
Doug Sherk, 415-652-9100
Source: STAAR Surgical Company
